PLSE

PLSE

Pulse Biosciences, Inc.Full model view of PLSE →
OUTPERFORM

Company Information

SectorHealthcare
IndustryMedical - Instruments & Supplies
Market Cap$3.68B
Analysts Rating2.4/5

Recommendation Details

PortfolioMidcap
DateSep 14, 2026
ForecastQ Daily Probabilities
58.2%
80.6%
59.6%

Company Description

Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.

ForecastQ

Quantitative stocks signals powered by AI


The information provided is for educational purposes only and should not be considered financial advice. Past performance is not indicative of future results. ForecastQ is a research platform, a living documentation of an engineering experiment. We are not financial advisors.


© ForecastQ. All rights reserved.